Literature DB >> 8349638

Heterogeneity of recombinant human antithrombin III expressed in baby hamster kidney cells. Effect of glycosylation differences on heparin binding and structure.

B Fan1, B C Crews, I V Turko, J Choay, G Zettlmeissl, P Gettins.   

Abstract

To determine the effects of differences in glycosylation on the structure and functional properties of recombinant human antithrombin (rHAT), we have characterized the properties of the recombinant protein overexpressed by baby hamster kidney cells. Three forms of rHAT, I-III, were isolated which differed in affinity for heparin. Form I had the lowest affinity and contained a high proportion of highly branched complex carbohydrate. Form II had higher affinity and contained both complex and high mannose-type chains. Form III had the highest affinity and was similar to form II in the type of carbohydrate present, but had a lower level of glycosylation, consistent with the absence of carbohydrate at one of the four glycosylation sites. 1H NMR spectra of plasma HAT and rHAT forms I-III suggested very similar protein structures for all forms. Heparin pentasaccharide produced almost identical NMR perturbation difference spectra. The only functional difference found was in the rates of inactivation of factor Xa. Forms II and III gave second order rate constants similar to that of plasma HAT, whereas form I gave a biphasic inhibition, with the first phase having a rate about four times that of the other forms. We conclude that carbohydrate heterogeneity does not alter the structure of the HAT polypeptide or the heparin-induced conformational change, but does affect the heparin affinity and can alter the rate of proteinase inhibition.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349638

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation.

Authors:  Irene Martínez-Martínez; Adriana Ordóñez; José Navarro-Fernández; Angel Pérez-Lara; Ricardo Gutiérrez-Gallego; Rafael Giraldo; Constantino Martínez; Esther Llop; Vicente Vicente; Javier Corral
Journal:  Haematologica       Date:  2010-04-30       Impact factor: 9.941

2.  Protective effect of a newly developed fucose-deficient recombinant antithrombin against histone-induced endothelial damage.

Authors:  Toshiaki Iba; Tatsuhiko Hirota; Koichi Sato; Isao Nagaoka
Journal:  Int J Hematol       Date:  2018-01-20       Impact factor: 2.490

3.  Recombinant human pigment epithelium-derived factor (PEDF): characterization of PEDF overexpressed and secreted by eukaryotic cells.

Authors:  E Stratikos; E Alberdi; P G Gettins; S P Becerra
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

4.  Expression and production of pigment epithelium-derived factor (PEDF) and PEDF receptor variants from mammalian and bacterial cells.

Authors:  Jeanee Bullock; Federica Polato; Daniel C Lulli; Vatsala Sagar; Laura Abaandou; Joseph Shiloach; S Patricia Becerra
Journal:  Protein Expr Purif       Date:  2022-02-15       Impact factor: 1.650

5.  The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex.

Authors:  Chengliang Wu; Paul Y Kim; Reg Manuel; Marian Seto; Marc Whitlow; Mariko Nagashima; John Morser; Ann Gils; Paul Declerck; Michael E Nesheim
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

Review 6.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

7.  Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.

Authors:  E Ersdal-Badju; A Lu; X Peng; V Picard; P Zendehrouh; B Turk; I Björk; S T Olson; S C Bock
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

8.  Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure.

Authors:  Hiromitsu Kuroda; Yoshiki Masuda
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

9.  Control of post-translational modifications in antithrombin during murine post-natal development by miR-200a.

Authors:  Raúl Teruel; Irene Martínez-Martínez; José A Guerrero; Rocío González-Conejero; María E de la Morena-Barrio; Salam Salloum-Asfar; Ana B Arroyo; Sonia Águila; Nuria García-Barberá; Antonia Miñano; Vicente Vicente; Javier Corral; Constantino Martínez
Journal:  J Biomed Sci       Date:  2013-05-16       Impact factor: 8.410

10.  Comparison of biological activities of human antithrombins with high-mannose or complex-type nonfucosylated N-linked oligosaccharides.

Authors:  Tsuyoshi Yamada; Yutaka Kanda; Makoto Takayama; Akitoshi Hashimoto; Tsutomu Sugihara; Ai Satoh-Kubota; Eri Suzuki-Takanami; Keiichi Yano; Shigeru Iida; Mitsuo Satoh
Journal:  Glycobiology       Date:  2016-01-07       Impact factor: 4.313

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.